Monday, February 29, 2016

Valeant Chief Returns to a Difficult To-Do List by ROBERT CYRAN


By ROBERT CYRAN

Even if the drug maker’s delayed 2015 earnings are published soon, J. Michael Pearson’s room for maneuvering is shrinking.

Published: March 1, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1SduMlo



from WordPress http://ift.tt/21xij1H
via Hadi Aboukhater
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)